How many insider trades does FilingIQ track for JUNS?

FilingIQ tracks 53 Form 4 insider transactions for JUNS (JUPITER NEUROSCIENCES, INC.), covering filings from Jan 22, 2025 onwards. 10 of those were filed in the last 90 days.

Are JUNS insiders net buyers or net sellers?

Across the full Form 4 history for JUNS, 21 transactions (40%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does JUNS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is JUNS in?

JUPITER NEUROSCIENCES, INC. (JUNS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.94M.

JUNS insider trading

NasdaqCM Healthcare

JUPITER NEUROSCIENCES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

40% / 0%

Market cap

$9.94M

About JUPITER NEUROSCIENCES, INC.

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alzheimer's disease; JNS102, which is in Phase II clinical trial for the treatment of mucopolysaccharidosis type 1; and JNS107, which is in Phase II clinical trial for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. It is also involved in the commercialization and sale of GLO for skin beauty, MND for mental clarity, and PWR for energy, endurance, and muscle recovery under the Nugevia brand name. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.

Company website: jupiterneurosciences.com

JUNS insider activity at a glance

FilingIQ has scored 53 insider transactions for JUNS since Jan 22, 2025. The most recent filing in our index is dated Jun 29, 2026.

Across the full history, 21 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on JUNS insider trades is 57.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live JUNS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,070

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 215

Kymera Therapeutics, Inc.

HNGE 194

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for JUNS?: FilingIQ tracks 53 Form 4 insider transactions for JUNS (JUPITER NEUROSCIENCES, INC.), covering filings from Jan 22, 2025 onwards. 10 of those were filed in the last 90 days.
Are JUNS insiders net buyers or net sellers?: Across the full Form 4 history for JUNS, 21 transactions (40%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does JUNS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is JUNS in?: JUPITER NEUROSCIENCES, INC. (JUNS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.94M.

Methodology & sources

Every JUNS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.